A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

Name: A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma
License: Public Domain

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

open angle glaucoma, ocular hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 314454
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.